
NORWAY — The Planning Board voted Thursday evening to schedule a public hearing on a proposed medical marijuana grow facility.
The hearing on the proposal of a Lewiston man seeking to lease the former brick production facility of the Advertiser Democrat newspaper is set for 7 p.m. Sept. 14 at the Town Office.
Rob Laverdiere told the Planning Board on Thursday that he would be the “primary caregiver of the facility” and would have the “capability of having up to five patients with a maximum of six plants per patient, for a maximum of 30 plants total.”
He said there would be “no foot traffic” on the premises.
“There’s not going to be cars coming and going,” Laverdiere said. “It’s pretty much going to be a one-man band there.”
All parts of the marijuana plants would be used and recycled outside the premises, Laverdiere said, with the soil being recycled.
“There won’t be any hazardous waste or anything along those lines,” he said. “Also, each room will have an air handler, which will recycle the air in the individual rooms, so there won’t be any exhaust going to the outside.”
He said that “come spring, we want to add some lilies or bushes to clean up the street front.”
Laverdiere said that it will cost about $5,000 for the overall facility upgrades, including the creation of a second door for the building and cleaning the building.
“It’ll cost about $20,000 to create each room, which is a significant investment,” he added.
Comments are not available on this story. Read more about why we allow commenting on some stories and not on others.
We believe it's important to offer commenting on certain stories as a benefit to our readers. At its best, our comments sections can be a productive platform for readers to engage with our journalism, offer thoughts on coverage and issues, and drive conversation in a respectful, solutions-based way. It's a form of open discourse that can be useful to our community, public officials, journalists and others.
We do not enable comments on everything — exceptions include most crime stories, and coverage involving personal tragedy or sensitive issues that invite personal attacks instead of thoughtful discussion.
You can read more here about our commenting policy and terms of use. More information is also found on our FAQs.
Show less